Neurotrophin-3 (NT-3) as a Potential Biomarker of the Peripheral Nervous System Damage Following Breast Cancer Treatment

Neurotrophin-3 (NT-3) as a Potential Biomarker of the Peripheral Nervous System Damage Following Breast Cancer Treatment

Damage to the peripheral nervous system (PNS) is a common complication of breast cancer (BC) treatment, with 60 to 80% of breast cancer survivors experiencing symptoms of PNS damage. In the current study, the levels of brain-derived neurotrophic factor (BDNF), galectin-3 (Gal-3), and neurotrophin-3...

Full description

Bibliographic Details
Main Authors:	Samvel Tonyan, Maria Pospelova, Varvara Krasnikova, Olga Fionik, Tatyana Alekseeva, Konstantin Samochernykh, Nataliya Ivanova, Tatyana Vavilova, Elena Vasilieva, Albina Makhanova, Aleksandra Nikolaeva, Tatyana Bukkieva, Stephanie Combs, Maxim Shevtsov
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Pathophysiology
Subjects:	peripheral nervous system neuropathy postmastectomy pain syndrome chemotherapy-induced peripheral neuropathy radiation-induced peripheral neuropathy brain-derived neurotrophic factor
Online Access:	https://www.mdpi.com/1873-149X/30/2/10

Similar Items

Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes
by: Sebastian W. Nielsen, et al.
Published: (2022-03-01)

Managing treatment-related peripheral neuropathy in patients with multiple myeloma
by: Grammatico S, et al.
Published: (2016-06-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01)

Taxane-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2015-04-01)

The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01)

The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma
by: Karolina Łuczkowska, et al.
Published: (2021-10-01)

Bortezomib-induced neurotoxicity in human neurons is the consequence of nicotinamide adenine dinucleotide depletion
by: Andrew R. Snavely, et al.
Published: (2022-12-01)

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

Acupotomy and venesection in Upper Limb Lymphedema and Peripheral neuropathy following Breast Cancer Surgery
by: Jang Eun-ha, et al.
Published: (2009-12-01)

Physiopathological Role of Neuroactive Steroids in the Peripheral Nervous System
by: Eva Falvo, et al.
Published: (2020-11-01)

Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy
by: Roser Velasco, et al.
Published: (2021-12-01)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres
by: Jamie Burgess, et al.
Published: (2021-01-01)

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2021-07-01)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01)

Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
by: Pasquale Sansone, et al.
Published: (2022-08-01)

Electrophysiologic Patterns of Symptomatic Vincristine-Induced Peripheral Neuropathy in Children with Acute Lymphocytic Leukemia
by: Jae-Gyeong Jeong, et al.
Published: (2023-01-01)

The Effects of Nuclear Factor Erythroid 2 (NFE2)-Related Factor 2 (Nrf2) Activation in Preclinical Models of Peripheral Neuropathic Pain
by: Paramita Basu, et al.
Published: (2022-02-01)

Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis
by: Megan Crichton, et al.
Published: (2022-06-01)

A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy
by: Cindy Tofthagen, et al.
Published: (2022-01-01)

Ogilvie Syndrome in a Refractory Germ Cell Tumor Treated with Vinblastine, Ifosfamide and Cisplatin Regimen
by: Hrishi Varayathu, et al.
Published: (2020-09-01)

Exploring Outcome Priorities and Real-Life Management of Chemotherapy-Induced Peripheral Neurotoxicity: A Survey of the Italian Association for the Study of Pain members
by: Sardo S, et al.
Published: (2023-09-01)

Effect of hypertension on diabetic peripheral neuropathy
by: Ihsan M. Ajeena
Published: (2008-07-01)

Post-surgical inflammatory neuropathy after anterior cruciate ligament repair: a case report
by: Lisa Y. Sun, et al.
Published: (2024-04-01)

Corneal Confocal Microscopy: A Non-Invasive Surrogate Marker of Small Nerve Fibre Damage and Repair in Patients with Small Fibre Neuropathy
by: M Tavakoli, et al.
Published: (2005-10-01)

Corneal Confocal Microscopy: A Non-Invasive Surrogate Marker of Small Nerve Fibre Damage and Repair in Patients with Small Fibre Neuropathy
by: M Tavakoli, et al.
Published: (2005-03-01)

Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
by: Deborah Lee, et al.
Published: (2019-01-01)

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
by: Gihyun Lee, et al.
Published: (2016-09-01)

A study on prevalence of diabetic peripheral neuropathy in diabetic patients attending a rural health and training centre
by: K Karthiksaravanan, et al.
Published: (2024-01-01)

PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy
by: Christele Le Gouill-Jaijarat, et al.
Published: (2023-01-01)

Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management
by: Preston FG, et al.
Published: (2023-06-01)

Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region
by: Georgios Ponirakis, et al.
Published: (2022-09-01)

Recovery of brachial plexus lesions resulting from heavy backpack use: A follow-up case series
by: Pihlajamäki Harri K, et al.
Published: (2011-03-01)

Diabetic peripheral neuropathy therapy-induced activation of humoral serotonin and endogenous neurotrophins
by: Yuulia Vladimirovna Karakulova, et al.
Published: (2013-11-01)

Efficacy of electroacupuncture in the treatment of peripheral neuropathy caused by Utidelone: Study protocol for a randomized controlled trial
by: Chao Lu, et al.
Published: (2023-02-01)

Focal Peripheral Neuropathies (4th ed)
by: Colin Chalk
Published: (2010-10-01)

Elevated Creatinine Kinase in Peripheral Neuropathy Is Associated With Muscle Cramping
by: Allison Jordan, et al.
Published: (2021-02-01)

Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study
by: R. Dixon Dorand, et al.
Published: (2023-01-01)

Gender differences in Diabetic Peripheral Neuropathy
by: Mona Abosrea, et al.
Published: (2020-01-01)

Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
by: Kuniaki Tsutsumi, et al.
Published: (2016-06-01)